NEW FOCUS AUTO (00360) enters into a capital increase agreement with China Merchants Juxin.
New Focus (00360) announced that on November 17, 2025, Newport Electronics (Shanghai) (Company...
NEW FOCUS AUTO (00360) announced that on November 17, 2025, New Focus Opto-electronic (Shanghai) (an indirect wholly-owned subsidiary of the company) entered into a capital increase agreement with China Resources Ju Xin (as an investor). Under the agreement, China Resources Ju Xin agreed to inject RMB 100 million (equivalent to approximately USD 14 million) into New Focus Opto-electronic (Shanghai) for a 10.0% equity stake. After the capital injection, New Focus Opto-electronic (Shanghai) will be owned approximately 90.0% by the group and 10.0% by China Resources Ju Xin. New Focus Opto-electronic (Shanghai) will continue to operate as a subsidiary of the company, and its financial performance will continue to be consolidated into the group's financial statements.
New Focus Opto-electronic (Shanghai) is an indirect wholly-owned subsidiary of the company and serves as the operating entity for the group's manufacturing business, mainly producing and selling automotive electronic products including inverters, chargers, multi-function power supplies, and air-conditioning units.
The capital injection will introduce a new shareholder to New Focus Opto-electronic (Shanghai), providing additional capital for the company's growth and development. Considering the business resources of China Resources Ju Xin, the board of directors believes that China Resources Ju Xin will bring new synergistic business development opportunities to group member companies (especially New Focus Opto-electronic (Shanghai)) and provide various business and operational support to the group, thereby enhancing the overall business operations and financial performance of the group.
Related Articles

IVD MEDICAL (01931) on November 17th spent 3.639 million Hong Kong dollars to repurchase 593,000 shares.

MS CONCEPT (08447) announced a mid-term expected profit of approximately HK$3.4 million to HK$3.8 million, turning from a loss to profit year-on-year.

INT'L ENT(01009) plans to issue up to HK$1.6 billion worth of convertible bonds.
IVD MEDICAL (01931) on November 17th spent 3.639 million Hong Kong dollars to repurchase 593,000 shares.

MS CONCEPT (08447) announced a mid-term expected profit of approximately HK$3.4 million to HK$3.8 million, turning from a loss to profit year-on-year.

INT'L ENT(01009) plans to issue up to HK$1.6 billion worth of convertible bonds.

RECOMMEND

U.S. equities face “key defense lines,” testing bullish conviction; a break would confirm a downtrend into “early next year”
17/11/2025

Year-to-date Hong Kong share buybacks surpass HK$140 billion, with technology and financials leading activity
17/11/2025

Bitcoin’s year-to-date 30% rally “fully erased,” market slips into a bear phase
17/11/2025


